– GEN’s Editor-in-Chief John Sterling interviews Sukru Tuzmen , Ph.D., Investigator, Head of Molecular Genetics Laboratory , Pharmaceutical Genomics Division, Translational Genomics Research Institute (TGEN)

PodcastsResourcesAnti cancer drugsCancer drug discoveryCancersClinical laboratory techniqueComputational biologyComputational molecular biologyDiagnosisDiagnostic techniquesDrug development (Research and development)Drug discoveryDrug research and developmentDrugsEarly-stage clinical drug developmentGene expression profilingInternal medicineMedical oncologyMedicineMedicine, Diagnosis, and TherapeuticsMolecular techniqueNovel targets identificationPharmacologyReal time PCRResearch and developmentSystemic conditionsTechnology and Computational Biology
Previous articleGreenovation Biotech Granted U.S. Patent on Plant-Based Glyco-Engineering
Next articleOncolys and Tacere Forge Alliance to Develop RNAi HCV Drug